A Phased Approach to Resuming Suspended Allergy/Immunology Clinical Services is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2020). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Agency for Healthcare Research and Quality
Grant: 5K08HS024599-02
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Grant: K23AR070897
AHRQ HHS
Grant: K08 HS024599
Asthma and Allergy Foundation of America
European Academy of Allergy and Clinical Immunology
Novartis
Bayer Corporation
Genentech
Merck
Abbott Nutrition
American Lung Association
CSL Behring
Food Allergy and Anaphylaxis Network
Jeffrey Modell Foundation
Australasian Society of Clinical Immunology and Allergy
Boettcher Foundation
Institute for Health Metrics and Evaluation
Johnson and Johnson
Shire
Teva Pharmaceutical Industries
AstraZeneca
Boehringer Ingelheim
American Academy of Allergy Asthma and Immunology
Genzyme
National Institutes of Health
North Carolina GlaxoSmithKline Foundation
Pfizer
Takeda Pharmaceuticals North America
Takeda Pharmaceuticals U.S.A.
Horizon Pharmaceuticals
National Institute of Allergy and Infectious Diseases
Sanofi
FWCI
4.52
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals